|
|
Cumming School of Medicine, University of Calgary
Cumming School of Medicine, University of Calgary
Dr. Savoi is a Clinical Associate Professor in the Departments of Medicine and Oncology at the University of Calgary as well as a member of the Department of Hematologic Malignancies and Bone Marrow Transplantation at the Tom Baker Cancer Centre in Calgary.
Her interests lie in myeloid malignancies, ALL, stem cell transplantation and medical education. Local primary investigator for a number of clinical trials including in CML and AML.
Savoie ML, Bence-Bruckler I; Huebsch LB, Lalancette M, Hillis C, Walker I, Lipton JH, Forrest DL, Kim DDH: Canadian chronic myeloid leukemia outcomes post-transplant in the tyrosine kinase inhibitor era, 2018, Leukemia Research, 73:67-75.
Garzon R, Savona M, Ba R, Andreef M, Gabrail N, Gutierrez M, Savoie M Lynn, Mau-Soresnen M, Wagner-Johnston N, Yee K, Unger TJ, Saint-Martin JR, Carlson R, Rashal T, Kashyap T, Klebanov B, Shacham S, Kauffman M, Stone R: A Phase I Clinical Trial of Single-Agent Selinexor in Acute Myeloid Leukemia, 2017, Blood, 129(4);3165-3174
Liu HD, Ahn KW, Hamadani M, Nishihori T, Wirk B, Beitinjaneh A, Rizzieri D, Grunwald MR, Sabloff M, Olsson RF, Bajel A, Bredeson C, Daly A, Inamoto Y, Majhail N, Saad A, Gupta V, Gerds A, Malone A, Tallman M, Reshef R, Marks DI, Copelan E, Gergis U, Savoie ML, Ustun C, Litzow MR, Cahn JY, Kindwall-Keller T, Akpek G, Savani BN, Aljuf M, Rowe JM, Wiernik PH, Hsu JW, Cortes J, Kalacyio M, Maziarz R, Sobecks R, Popat U, Alyea E, Saber : Allogeneic Hematopoietic Cell Transplant for Adult Chronic Myelomonocytic Leukemia, 2017, Biology of Blood and Marrow Transplantation, 23(5);767-775
DeAngelo DJ, Stevenson KE, Dahlberg SE, Silverman LB, Couban C, Suplo JG, Amrein PC, Ballen KK, Seftel MD, Turner AR, Leber B, Howson-Jan K, Kelly K, Cohen S, Matthews JH, Savoie L, Wadleigh M, Sirulnik LA, Galinsky I, Neuberg DS, Sallan SE, Stone RM: Long-term outcome of a pediatric-inspired regimen used for adults ages 18 to 50 with newly diagnosed acute lymphoblastic leukemia, 2015, Leukemia, Mar:29(3):526-34.
Couban S, Savoie L, Mourad YA, Leber B, Minden M, Turner R, Palada V, Shehata N, Christofides A, Lachance S: Evidence-based guidelines for the use of tyrosine kinase inhibitors in adults with Philadelphia chromosome-positive or BCR-ABL-positive acute lymphoblastic leukemia: a Canadian consensus, 2014, Current Oncology, Apr;21(2):e265-309.
Savoie ML, Bence-Bruckler I; Huebsch LB, Lalancette M, Hillis C, Walker I, Lipton JH, Forrest DL, Kim DDH: Canadian chronic myeloid leukemia outcomes post-transplant in the tyrosine kinase inhibitor era, 2018, Leukemia Research, 73:67-75.
Garzon R, Savona M, Ba R, Andreef M, Gabrail N, Gutierrez M, Savoie M Lynn, Mau-Soresnen M, Wagner-Johnston N, Yee K, Unger TJ, Saint-Martin JR, Carlson R, Rashal T, Kashyap T, Klebanov B, Shacham S, Kauffman M, Stone R: A Phase I Clinical Trial of Single-Agent Selinexor in Acute Myeloid Leukemia, 2017, Blood, 129(4);3165-3174
Liu HD, Ahn KW, Hamadani M, Nishihori T, Wirk B, Beitinjaneh A, Rizzieri D, Grunwald MR, Sabloff M, Olsson RF, Bajel A, Bredeson C, Daly A, Inamoto Y, Majhail N, Saad A, Gupta V, Gerds A, Malone A, Tallman M, Reshef R, Marks DI, Copelan E, Gergis U, Savoie ML, Ustun C, Litzow MR, Cahn JY, Kindwall-Keller T, Akpek G, Savani BN, Aljuf M, Rowe JM, Wiernik PH, Hsu JW, Cortes J, Kalacyio M, Maziarz R, Sobecks R, Popat U, Alyea E, Saber : Allogeneic Hematopoietic Cell Transplant for Adult Chronic Myelomonocytic Leukemia, 2017, Biology of Blood and Marrow Transplantation, 23(5);767-775
DeAngelo DJ, Stevenson KE, Dahlberg SE, Silverman LB, Couban C, Suplo JG, Amrein PC, Ballen KK, Seftel MD, Turner AR, Leber B, Howson-Jan K, Kelly K, Cohen S, Matthews JH, Savoie L, Wadleigh M, Sirulnik LA, Galinsky I, Neuberg DS, Sallan SE, Stone RM: Long-term outcome of a pediatric-inspired regimen used for adults ages 18 to 50 with newly diagnosed acute lymphoblastic leukemia, 2015, Leukemia, Mar:29(3):526-34.
Couban S, Savoie L, Mourad YA, Leber B, Minden M, Turner R, Palada V, Shehata N, Christofides A, Lachance S: Evidence-based guidelines for the use of tyrosine kinase inhibitors in adults with Philadelphia chromosome-positive or BCR-ABL-positive acute lymphoblastic leukemia: a Canadian consensus, 2014, Current Oncology, Apr;21(2):e265-309.
DEPARTMENT OF ONCOLOGY
TOM BAKER CANCER CENTRE
1331 29th STREET NW CALGARY AB CANADA T2N 4N2
